ID
11862
Description
Alemtuzumab in Autoimmune Inflammatory Neurodegeneration: Mechanisms of Action and Neuroprotective Potential (ALAIN01) https://clinicaltrials.gov/ct2/show/NCT02419378 Principal Investigator Prof. Dr. Dr. Sven Meuth, University Hospital Muenster, Germany
Link
https://clinicaltrials.gov/ct2/show/NCT02419378
Keywords
Versions (4)
- 2015-08-13 2015-08-13 - Martin Dugas
- 2016-05-22 2016-05-22 -
- 2016-05-28 2016-05-28 -
- 2016-06-03 2016-06-03 -
Uploaded on
13 augusti 2015
DOI
To request one please log in.
License
Creative Commons BY-NC 3.0 Legacy
Model comments :
You can comment on the data model here. Via the speech bubbles at the itemgroups and items you can add comments to those specificially.
Itemgroup comments for :
Item comments for :
In order to download data models you must be logged in. Please log in or register for free.
Evoked Potentials Multiple Sclerosis ALAIN01 NCT02419378
Evoked Potentials Multiple Sclerosis ALAIN01 NCT02419378
- StudyEvent: SE
Similar models
Evoked Potentials Multiple Sclerosis ALAIN01 NCT02419378
- StudyEvent: SE